Jeena Sikho Lifecare Limited
BSE: JSLL · Pharmaceuticals
Snapshot
Unlock Jeena Sikho Lifecare Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Jeena Sikho Lifecare is a prominent Indian healthcare provider specialising in ayurvedic treatment systems. The company operates an extensive network of hospitals and clinics across multiple states to deliver integrated wellness services.
Business Model
The company generates revenue by operating a chain of ayurvedic hospitals and daycare clinics that provide healthcare services to patients. Its model relies on scaling physical infrastructure to capture demand for traditional medicine across diverse Indian cities.
- Operational Hospitals:36
- Clinics/Daycare Centres:74
- Operational Beds:1,530
Growth Outlook
The company is actively expanding its healthcare footprint by adding 518 new beds to its existing hospital network. This infrastructure pipeline is intended to increase patient capacity and market penetration across its operational regions.
- Beds in Pipeline:518
Key Risks
- Regulatory Risk. Changes in government regulations regarding ayurvedic medicine and healthcare standards could impact operational compliance and costs.
- Execution Risk. The rapid expansion of hospital and clinic networks may face challenges related to staffing, quality control, and capital expenditure management.
- Market Acceptance. The company's growth depends on the continued public preference for ayurvedic healthcare systems over conventional allopathic treatments.
- Geographic Concentration. Operating across 21 states introduces complexities in managing regional logistics, supply chains, and varying local healthcare demand.
Start your research today
Unlock AI insights, financials, peers and live data on Jeena Sikho Lifecare Limited and 5,000+ companies — free.
Key Metrics
P/E
27.1x
Q1 FY27 · consolidated
EV/EBITDA
16.6x
Q1 FY27 · consolidated
NET PROFIT MARGIN
29.4%
Q1 FY27 · consolidated
Peers · Pharmaceuticals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Jeena Sikho Lifecare LimitedJSLL | ₹6,418 Cr | 27.15 | 16.65 | — | 45.2% | 50.6% | 58.2% | -33.7% |
Supriya Lifescience LimitedSUPRIYA | ₹6,864 Cr | 34.60 | 22.66 | 28.1% | 34.5% | 18.1% | 23.8% | +30.1% |
Innova Captab LimitedINNOVACAP | ₹6,726 Cr | 43.68 | 26.28 | 34.5% | 15.4% | 15.0% | 17.4% | +27.9% |
Senores Pharmaceuticals Ltd.SENORES | ₹6,578 Cr | 50.30 | 29.26 | — | 34.7% | 15.2% | 18.4% | +102.9% |
Sun Pharma Advanced Research Company LimitedSPARC | ₹6,473 Cr | 4.09 | 4.28 | 2855.8% | 86.0% | 282.4% | 235.1% | +38.2% |
Morepen Laboratories LimitedMOREPENLAB | ₹6,232 Cr | 44.43 | 31.03 | 9.5% | 10.6% | 11.7% | 14.4% | +129.7% |
As of Q1 FY27
Financials
Jeena Sikho Lifecare Limited
BSE: JSLL · Pharmaceuticals
Snapshot
Unlock Jeena Sikho Lifecare Limited's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Jeena Sikho Lifecare is a prominent Indian healthcare provider specialising in ayurvedic treatment systems. The company operates an extensive network of hospitals and clinics across multiple states to deliver integrated wellness services.
Business Model
The company generates revenue by operating a chain of ayurvedic hospitals and daycare clinics that provide healthcare services to patients. Its model relies on scaling physical infrastructure to capture demand for traditional medicine across diverse Indian cities.
- Operational Hospitals:36
- Clinics/Daycare Centres:74
- Operational Beds:1,530
Growth Outlook
The company is actively expanding its healthcare footprint by adding 518 new beds to its existing hospital network. This infrastructure pipeline is intended to increase patient capacity and market penetration across its operational regions.
- Beds in Pipeline:518
Key Risks
- Regulatory Risk. Changes in government regulations regarding ayurvedic medicine and healthcare standards could impact operational compliance and costs.
- Execution Risk. The rapid expansion of hospital and clinic networks may face challenges related to staffing, quality control, and capital expenditure management.
- Market Acceptance. The company's growth depends on the continued public preference for ayurvedic healthcare systems over conventional allopathic treatments.
- Geographic Concentration. Operating across 21 states introduces complexities in managing regional logistics, supply chains, and varying local healthcare demand.
Start your research today
Unlock AI insights, financials, peers and live data on Jeena Sikho Lifecare Limited and 5,000+ companies — free.
Key Metrics
P/E
27.1x
Q1 FY27 · consolidated
EV/EBITDA
16.6x
Q1 FY27 · consolidated
NET PROFIT MARGIN
29.4%
Q1 FY27 · consolidated
Peers · Pharmaceuticals
As of Q1 FY27